Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is what I took out of b402s post and why I think Bestbuy makes the most sense....explains the CEO buying 2.5m shares open market
With 25m in annual revenue and about to double that you could be right and they could be getting ready for an uplisting. That is pretty obvious but Nasdaq is still a ways off.
You think Best buy is the retailer?
I agree...Sounds like Best buy is a great choice...makes a lot of sense. However I also understand they are negotiating with major studios to expand the rapidly growing 4k studio revenues. Which studio do you think it is?
$33k is a nice price point to up convert.
Best buy is the logical choice and my guess. Running at 25m in revenue now and getting ready to add all the new revenues in has attracted a lot of attention. I also read that the founder of red box was brought on by the company as well as some other top notch folks.
Been reading through this...are people actually saying the CEO bought 2.5m shares recently...last coup!e weeks to turn around and sell them back and lie in the filings and break SEC rules?
It is a profitable company, crazy undervalued...about to double its revenues.
Exactly. The CC already covered the items regarding all the opioids. More misinformation being presented below.
Dr L, listen to the CC!!!!!
People should read what tangerine wrote. You indeed proved Elite to be superior over the one bead. I hadn't thought about the polymers that way but by separating the beads you make it much easier to develop more products. Nasrat is looking at 15 as soon as they can. If they had polymer concerns over each product and their sequestering requirements, you would need much more development and it would be much more complicated..... It is funny how things work sometimes.
Lol. Tang is correct. You did just prove Elite's tech is superior. Seems you need him to explain it to you but it is pretty obvious and truly LOL LOL
Any actual investors looking for actual information about why the stock price has been going up up up
http://www.elitepharma.com/
Listen to this CC replay
When: Tuesday, February 18, 2014 at 3:00 PM Eastern
A digital telephone replay will be available approximately one hour after the conclusion of the call for two weeks until March 4, 2014 by dialing:
Domestic callers: (800) 332-6854
International callers: (973) 528-0005
Conference entry code: 98840
Anyone truly interested in the truth about Naloxone and whether it is fast acting and whether it is a good antagonist for ADT. Just Google it. Ask a nurse or health professional. Heck just read the wiki on it. There is a reason Naltrexone is chosen.
I could go back and forth all night. So if anyone really wants to know just take 10 minutes.
Purdue has a product overseas they would like to backdoor for ADT. Naloxone is very fast acting and has a short life. Let's not make people ill and then get them high...OK? And it has little bearing on Elite today.
Elite will be fast tracked. No question about it.
Then don't buy the stock in a week or two. However the CFO basically told you what was probably going to happen. Can you tell me what he said?
Naloxone is fast acting and short lived. It is what they give people that are overdosing when they come to the emergency room.....because it is fast acting...you need a link for basic pharmaceutical knowledge? Just Google it...
That is why despite your claims Pfizer and Elite use Naltrexone.
People can research it although it is not really significant here. Targin has been approved overseas and not thought of or labeled there for abuse deterence.
Very possible. This was also discussed on the CC. Elite wants to make ton of products and drive the value of the company sky high and also have leverage with a partner. They have been meeting with big pharmas but without the leverage of doing as many of these as they can on their own, they lose some of their bargaining power and they will not accept a less then fair deal. All discussed on the CC
Targin is a pain med ...oxy..to also relieve constipation because it has naloxone released. Which is sort of ironic.
However Naloxone is fast acting so if you crush it, you will probably suffer short term possibly severe withdrawal symptoms, then you will get high but at least you will be abke to take a dump easier....nice ADT product there.
What I do find so interesting about Targin is that Elite could make a Targin type product where they also included their naltrexone beads thus making the product much more effective as an ADT product.
Here it is in a nutshell
First you said no one cares and then you said it only applies to 505j. So no one cares about 505j generics? And anyone that knows anything about 505b2 knows efficacy is not always required and BE trials suffice so that corrects both of your comments actually. Just check the FDA website if you don't believe me.
Ahhh...I see the next patent just concluded it's gating items in the database....so that will be announced shortly...
Efficacy is not needed as has been explained over and over and your comment is obviously false. Generic drugs only require BE trials so I am guessing all those pharma companies working on generics all across the world would disagree.
As I note, Elite will be seeking and expecting to receive drug approvals based on the trials you claim are insignificant which is obviously not accurate in any way. I am going too believe the experts in camargo and the FDA and common sense here.
So what product do you think this second one is here? Embeda? Percodan? Oxy IR?
Huh? Trial results on the second big product are about to be announced. Anyone in Pharma knows that positive 505b2 trials are huge. Only thing left is the abuse studies and based on simple chemistry we all know they will pass. Basically it means you will have a product that will be approved. And Elite can make all of them as noted into he call with 15 planned. Basically it means that Elite is incredibly undervalued at current levels.
You are looking at a 3.5 billion dollar market just on these four initial products.
I have no idea what your point is. Elite is expecting to release trial results in the next week or two as noted on the CC. They also expect to have excellent results as noted on the CC. They did also note the patent too.
Isradipine is also around the corner I believe
Abuse deterrent formulations are expected to drive the 8 billion dollar market so what you are saying is bizarre. The FDA and all levels of government consider it a major health priority.
The FDA has already pulled Oxycontin ANDAs and not approved others because it is dangerous. Google oxycontin deaths. Wow...seriously?
Their own guidance on abuse deterrent drugs call it a "high public health priority"
Drug doctor I agree,
500m cap estimate sounds good.
I agree Drug Doctor
Drug Doctor,
I agree
I see we are having our daily fictitious reverse split discussion. How come no forward split discussion? Anyway, seems everyone is predicting a record quarter which is cool.
But the real talk is going to be about partnerships, trials, and products.
They already make revenue above operational costs outside of their massive R&D. Its in the filings and was discussed by the CFO on the last CC. They are spending millions on trials obviously....so what are you saying exactly?
Yeah. Ryan it looks like you are correct.
Good post. Well put.
I believe so.
We may just get a straight partnership. But there are multiple drugs right now so which ones get partnered?
We have a pivotal trial completing shortly to submit for approval to the FDA on one product. I suspect a crush study may be needed...maybe not...not sure we need to partner on this one.
I imagine you can find it in the posts from tangerine almost two years ago. Old news. Just read the Eckoboni declaration and review the charts provided. Or call the USPTO.
That is obviously not what I said.
You clearly did.
I read the data myself too. Why don't you go back to the original patent attachments for the two patents that have been awarded and read it for yourself? This is almost 2 year old stuff.
Yeah for sequestering Naltrexone in their abuse formulations. Put head to head with Purdues recommended Elites formulation and polymer blew them away...and that is a fact. Don't believe me? Read the patents and testing that was done.
That would be correct and the USPTO agrees with you.
You need an asset to give to a partner for either their company, cash, partnership, merger. These I shares will be that vehicle.
So if we merged with Epic which makes a ton of sense right now, we would give them some number of these preferred based on some defined PPS.
If a pharma partner wants a part of Elite instead or in addition to a % of sales revenue, they would get these shares.
Same with a big financing deal.
Really very little is actually new with this 8k except the creation of these shares.
The number of shares is dependant on the price. The conversion price is just for conversion not the price that is paid. Thus the number of shares is dependent on the price....just like the LPC deal.
The RS talk has been nonsense. Every filing of this type regarding preferred will have the same/similar language on how they would deal with reverse and forward splits.
There is truth and there is perception. Truth is there is little new in the 8k except the creation of an I preferred share. Lasers, tangerine, myself, rob888 have presented facts. Will the misinformation and misinterpretation out there allow traders to make a move and try to manipulate things?
I have no idea. I do know that something big is about to happen for the company which always has the manipulators eager and willing to do what it takes to get people out of their stock. Such is the "market".
Unless you can tell me what is soooo bad about this 8k which really only opened the door for Elite's next move whether it be financing, merger, partnership acquisition or combination of these.
So tell me what was bad or agree we are really just talking about manipulation.